gray glp-1 weight loss drug study finds small increase in risk of osteoporosis and gout GLP-1 Receptor Agonists Linked to
Description
During this period, Tirzepatides dual action on GLP-1 and GIP receptors helps regulate appetite and improve the bodys natural response to insulin, allowing for gradual, sustainable fat loss rather than rapid fluctuations

I simply can't say enough good things about Affinity! Elizabeth R

Despite this growth, access to GLP-1RAs remains uneven globally

Weight regain after medication discontinuation is expected and should not be viewed as treatment failure

The rate of non-live births was similar between the two groups: 29.7% among women who continued GLP-1 medications 27.1% among women who discontinued them After accounting for differences in individual risk factors, the researchers found no statistically significant difference
This is especially helpful to do when you first start taking new drugs or using a combination of treatments
